Jacobs Jeffrey W 4
4 · ARDELYX, INC. · Filed Nov 16, 2021
Insider Transaction Report
Form 4
ARDELYX, INC.ARDX
Jacobs Jeffrey W
Chief Scientific Officer
Transactions
- Sale
Common Stock
[F1]2021-11-15$1.13/sh−5,000$5,650→ 125,237 total
Footnotes (1)
- [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 29, 2021.
Signature
/s/ Elizabeth Grammer, Attorney-in-Fact for Jeffrey W. Jacobs|2021-11-16